Bioequivalence of fixed‐dose combinations of dapagliflozin and metformin with single‐component tablets in healthy subjects and the effect of food on bioavailability

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 118-130

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects: A Randomized, Open-Label, Crossover Study

By Migoya Elizabeth M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 855-866

Adis International

Access to resources Recommend Favorite

Fixed-Dose Combination Tablet of Repaglinide and Metformin is Bioequivalent to Concomitantly Administered Individual Tablets of Repaglinide and Metformin: Randomized, Single-Blind, Three-Period Crossover Study in Healthy Subjects

By Hoelscher David  

Clinical Drug Investigation, Vol. 28, Iss. 9, 2008-01 ,pp. : 573-582

Adis International

Access to resources Recommend Favorite

Metformin Extended Release: Metformin Gastric Retention, Metformin GR, Metformin XR

By Adis International Limited  

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 316-319

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study

By Kandhwal Kirti  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 853-863

Adis International

Access to resources Recommend Favorite